Market Access

Find out everything you need to know about the latest pricing, reimbursement and market access strategies that will drive your business development.

Underwritten In Our Genes

Contributor: Tom Macfarlane
Posted: 10/6/2015

Underwritten In Our Genes - Tom Macfarlane

One of the more creative responses to the US firearms debate, a response currently circulating social media with no easily identifiable origin, is to retain the right to bear arms whilst simultaneously introducing mandatory gun-owners' insurance, thus positioning these two industrial behemoths for a fiscal fight to the death. Full Article »

Events related to this topic:

Preventing Type 2 Diabetes in the MENA Region

Contributor: Andrea Charles
Posted: 12/20/2011

Preventing Type 2 Diabetes in the MENA Region - Andrea Charles

Diabetes is a global threat. Researchers estimate that 26.6 million people in the Middle East and North Africa currently have diabetes. Six countries in the region are among the top 10 globally with the highest prevalence of diabetes. In this interview diabetes expert Professor Peter Schwarz, talks about the alarming growth of diabetes in the MENA region and strategies for prevention and management. Full Podcast »

Events related to this topic:

New Cardiovascular Drug Bucks Competitive Oncology-Only Trend in UK Early Access to Medicines Scheme - Dr Steven Bradshaw & Dr David Carr

One year on since the launch of the UK's Early Access to Medicines Scheme (EAMS), Novartis’ investigational heart failure drug LCZ696 (sacubitril/valsartan) has become the fifth therapy to be awarded a 'promising innovative medicine' (PIM) designation. Significantly for health technology manufacturers, LCZ696 is the first non-oncology therapy to receive a PIM, which, as Pharma IQ columnists Dr Steven Bradshaw and Dr David Carr discuss, is an important step for broadening early access to a wider range of medicines. Full Column »

Events related to this topic:

Connect with Pharma & Biotech Key Players - Your Ultimate Resource Pack

In this whitepaper you will find out what it takes to successfully engage with pharma and biotech key players. Are you looking for a ways to showcase your solution in front of pharma and biotech industry? Have you got interesting case study to share with our audience? Full Whitepaper »

Events related to this topic:

Advertise With Us

Join the Pharmas IQ Community